Tatva Chintan Pharma Chem Limited (IN:TATVA)
:TATVA
Want to see IN:TATVA full AI Analyst Report?
TATVA Stock Chart & Stats
₹1388.35
-₹14.30(-1.60%)
At close: 4:00 PM EST
₹1388.35
-₹14.30(-1.60%)
Day’s Range― - ―
52-Week Range₹862.85 - ₹1,603.60
Previous CloseN/A
Volume13.99K
Average Volume (3M)12.52K
Market Cap
₹29.33B
Enterprise Value₹29.76B
Total Cash (Recent Filing)₹178.47M
Total Debt (Recent Filing)₹830.13M
Price to Earnings (P/E)51.4
Beta1.04
Next Earnings
Jul 29, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield0.07%
Share Statistics
EPS (TTM)7.58
Shares Outstanding23,392,056
10 Day Avg. Volume25,333
30 Day Avg. Volume12,516
Financial Highlights & Ratios
PEG Ratio-3.55
Price to Book (P/B)2.24
Price to Sales (P/S)4.33
P/FCF Ratio-32.09
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)27
Revenue Forecast (FY)₹6.21B
Bulls Say, Bears Say
Bulls Say
Low Leverage / Strong Equity BaseA low debt-to-equity ratio and robust equity ratio provide durable financial flexibility, lowering liquidity and refinancing risk. This supports the company through cyclical demand in chemicals, allows funding of qualifying customer projects, and underpins long-term capital allocation decisions.
Diversified Specialty Chemical PortfolioServing pharma, agrochemical and energy-storage markets with PTCs, electrolyte salts and intermediates gives structural demand diversification. Multiple end-markets reduce reliance on any single sector and support recurring revenue from customer-qualified specialty products over multi-year cycles.
Operational Cash GenerationPositive operating cash conversion indicates the core chemical manufacturing business generates cash from operations. That cash backing of earnings supports working capital needs and customer servicing, enabling sustained operations even while investment cycles or capex programs run.
Bears Say
Persistent Negative Free Cash FlowSustained negative free cash flow driven by heavy capex strains liquidity and reduces financial flexibility. Over months, this can pressure cash reserves or force external financing, complicating the firm's ability to fund growth, dividends, or weather demand slowdowns without executing returns on those investments.
Recent Revenue Decline / Inconsistent GrowthA recent drop in revenue and an inconsistent growth pattern raise concerns about demand stability or customer retention. Over a multi-month horizon this can affect capacity utilization, margin recovery, and the payoff timeline for new product approvals or scale-up investments.
Volatile And Weakened Net Profit MarginsMarked margin volatility and a sharp net margin decline signal exposure to cost pressures or product-mix shifts. Persistent margin instability undermines predictable cash flows and return metrics, complicating long-term planning and potentially limiting reinvestment capacity if margins don't stabilize.
Tatva Chintan Pharma Chem Limited News
TATVA FAQ
What was Tatva Chintan Pharma Chem Limited’s price range in the past 12 months?
Tatva Chintan Pharma Chem Limited lowest stock price was ₹862.85 and its highest was ₹1603.60 in the past 12 months.
What is Tatva Chintan Pharma Chem Limited’s market cap?
Tatva Chintan Pharma Chem Limited’s market cap is ₹29.33B.
When is Tatva Chintan Pharma Chem Limited’s upcoming earnings report date?
Tatva Chintan Pharma Chem Limited’s upcoming earnings report date is Jul 29, 2026 which is in 69 days.
How were Tatva Chintan Pharma Chem Limited’s earnings last quarter?
Tatva Chintan Pharma Chem Limited released its earnings results on May 16, 2026. The company reported ₹4.7 earnings per share for the quarter, missing the consensus estimate of ₹6.4 by -₹1.7.
Is Tatva Chintan Pharma Chem Limited overvalued?
According to Wall Street analysts Tatva Chintan Pharma Chem Limited’s price is currently Overvalued.
Does Tatva Chintan Pharma Chem Limited pay dividends?
Tatva Chintan Pharma Chem Limited pays a Annually dividend of ₹1 which represents an annual dividend yield of 0.07%. See more information on Tatva Chintan Pharma Chem Limited dividends here
What is Tatva Chintan Pharma Chem Limited’s EPS estimate?
Tatva Chintan Pharma Chem Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Tatva Chintan Pharma Chem Limited have?
Tatva Chintan Pharma Chem Limited has 23,392,056 shares outstanding.
What happened to Tatva Chintan Pharma Chem Limited’s price movement after its last earnings report?
Tatva Chintan Pharma Chem Limited reported an EPS of ₹4.7 in its last earnings report, missing expectations of ₹6.4. Following the earnings report the stock price went up 1.363%.
Which hedge fund is a major shareholder of Tatva Chintan Pharma Chem Limited?
Currently, no hedge funds are holding shares in IN:TATVA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Tatva Chintan Pharma Chem Limited
Tatva Chintan Pharma Chem Limited manufactures and sells specialty chemicals in India. The company offers a portfolio of structure directing agents for zeolites synthesis; phase transfer catalysts; electrolyte salts for super capacitor batteries; and pharmaceutical APIs, agrochemical products, and other specialty chemicals in the form of intermediates, disinfectants, catalysts, and solvents. It also provides quaternary compounds and quats, and bulk drugs, as well as trading of specialty chemicals. It serves various industries, including the automotive, petroleum, pharmaceutical, agro-chemicals, paints and coatings, dyes and pigments, personal care, and flavor and fragrances industries. The company also exports its products to approximately 25 countries. Tatva Chintan Pharma Chem Limited was incorporated in 1996 and is headquartered in Vadodara, India.
Technical Analysis
Fineotex Chemical Limited
―
IOL Chemicals & Pharmaceuticals Ltd.
―
Kiri Industries Limited
―
Punjab Chemicals & Crop Protection Ltd.
―
Yasho Industries Ltd.
―